神农肝脂宁治疗脂肪肝的临床观察

目的观察神农肝脂宁治疗脂肪肝的疗效及安全性。方法选择脂肪肝患者 190例 ,随机分为两组 ,治疗组 14 2例口服神农肝脂宁 ,对照组 4 8例口服脂必妥 ,疗程 3个月。观察治疗后的症状体征、肝功能、血脂、血液黏度、影像学指标和临床综合疗效。结果治疗组和对照组总有效率分别为 80 98%及75 0 0 % ,两组比较差异有显著性 ,治疗组明显高于对照组 (P <0 0 5 )。治疗组在恢复肝功能 ,改善血脂、血液黏度和影像学方面均取得满意效果 ,未发生严重不良反应。结论神农肝脂宁治疗脂肪肝疗效显著 ,安全性良好。

英文摘要:

Objective To observe the therapeutic effect and safety of Shennong Ganzhining (SG) in treating fatty liver. Methods One hundred and ninety patients with fatty liver were randomly divided into two groups. The 142 patients in the treated group received SG and the 48 in the control group received Zhibituo treatment for 3 months. The comprehensive therapeutic effect after treatment, symptoms, signs, liver function, blood lipids and blood viscosity, as well as iconographic parameters were observed. Results The total effective rate in the treated group was 80 98%, which was higher than that in the control group (75 00%), showing significant difference statistically ( P <0 05). Satisfactory effect was obtained in recovery of liver function, improvement of blood lipids, blood viscosity and iconographic parameters, no severe adverse reaction occurred. Conclusion SG is obviously effective in treating fatty liver with favorable safety.

关闭